dc.contributor.author |
Abdelrahim, Wafaa Mohammed Abdulla |
|
dc.contributor.author |
Supervisor,- Abdelbagi Elnagi Mohamed |
|
dc.date.accessioned |
2013-11-07T09:29:14Z |
|
dc.date.available |
2013-11-07T09:29:14Z |
|
dc.date.issued |
2011-10-01 |
|
dc.identifier.citation |
Abdelrahim,Wafaa Mohammed Abdulla.Sero-detection of Cytomegalovirus Antibodies among Hemodialysis Patients in Khartoum State/Wafaa Mohammed Abdulla Abdelrahim;Abdelbagi Elnagi Mohamed.-Khartoum:Sudan University of Science and Technology,college of Medical Laboratory Science,2011.-48p. : ill. ; 28cm.-M.Sc. |
en_US |
dc.identifier.uri |
http://repository.sustech.edu/handle/123456789/2114 |
|
dc.description |
Thesis |
en_US |
dc.description.abstract |
The main aim of this study was to determine the seroprevalence of human
cytomegalovirus (HCMV) antibodies (IgG and IgM) using Enzyme-
Linked Immunosorbent Assay (ELISA), among 160 hemodialysis
patients and 40 apparently healthy control in Khartoum State.
Hemodialysis patients in this study were selected from Ibn Sina
Specialized Hospital, Khartoum North Renal Center and Omdurman
Teaching Hospital. Of the 160 dialysis patients 107 were males (65.6%)
and 53 were females (33.1%) and their ages ranged from 14 to 90 years.
The subgroups of hemodialysis patients were, 110 hepatitis-negative
(68.8%), 26 HBV-positive (16.3%) and 24 HCV-positive (15.0%). Out of
the 40 control subjects,19 were males (47%) and 21were females (53%)
and their ages ranged from14 to73 years. The prevalence of CMV
antibodies was high among both the hemodialysis patients (98.12%) and
the control group (100%). While 157 hemodialysis patients were anti-
CMV IgG positive (98.12%), only 3 were negative (1.88%). Among
different hemodialysis patients subgroups, 108 hepatitis-negative
(98.2%), 26 HBV-positive (100%) and 23 HCV-positive (95.5%) were
positive to anti-CMV IgG and there was no significant difference (p >
0.05) between them. It was found that 105 males (98.13%) and 52
females (98.11%) were anti-CMV IgG positive and there was no
significant difference (p > 0.05) between both genders. In contrast, all 40
control subjects (males and females ) were positive for anti-CMV IgG
(100%). Out of the 11 anti-CMV IgM positive dialysis patients (6.9%) 5
were hepatitis-negative (45.5%), 4 were HBV-positive (36.4%) and 2
were HCV-positive (18.2%) and there was no significant difference (p >
0.05) between them. The study also found that 8 males (72.7%) and 3
females (27.3%) were anti-CMV IgM positive and there was no
significant difference (p > 0.05) between them. In additition, out of the 11
control subjeccts 4 males (36.4%) and 7 females (63.6%) were anti-CMV
IgM positive (27.0%) and there was no significant difference (p>0.05)
between them. Furthermore, this study found that the main risk factor for
primary or past infection of CMV was aging and for secondary infection
or reinfection or reactivation of virus was blood transfusion. However,
hepatitis viruses, sex,the marital status, chronicity of
hemodialysis,
multiple hemodialysis, blood transfusion, and the crowdness were not
risk factors for CMV infections. |
en_US |
dc.description.sponsorship |
Sudan University of Science and Technology |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Sudan University of Science and Technology |
en_US |
dc.subject |
Cytomegalovirus |
en_US |
dc.title |
Sero-detection of Cytomegalovirus Antibodies among Hemodialysis Patients in Khartoum State |
en_US |
dc.title.alternative |
الكشف المصلي للأجسام المضادة للفيروس المضخم للخلاياعند مرضى
الإستصفاء
الدموي في ولايةالخرطوم |
|
dc.type |
Thesis |
en_US |